Last Price
Where today's price sits in its 52-week range
Orion Infusion Ltd. ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটি মোটামুটি অবস্থায় আছে (আমাদের বিশ্লেষণে 100-এর মধ্যে 55)। কোম্পানিটি লাভ করছে, তবে গত বছরের তুলনায় মুনাফা কিছুটা কমেছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক বেশি। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 0.7%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Wait & Watch
Watch listAverage company, very little trading
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks pricey right now — costs more than usual for what you get.
P/E Ratio
173.0
Price per ৳1 of yearly earnings
Dividend Yield
0.70%
Annual cash return on the price
P/B Ratio
18.6
Price per ৳1 of net assets
Trading at 173.0 — above its 5-year average of 133.7.
The raw figures behind the verdict — for the curious.
EPS
৳1.72
Earnings per share (latest year)
P/E Ratio
182.4
Price you pay per ৳1 of earnings
Dividend Yield
0.70%
Annual cash return on the price
Reserve & Surplus
৳12.3 Cr
Company's accumulated savings
Total Loan
৳30.6 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Made a profit every year for 5 years.
Earnings Per Share
Profit you earn per share
Earnings per share have been growing — ৳1.7 latest.
Yearly Cash Dividend
% of face value
📢 New 20% dividend just declared
Paid a dividend every year for 5 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Down 4.9% in the past week, lagging the overall market.
Past week
-4.9%
Price move over 7 days
Vs market
-5.6%
Ahead/behind the DSEX index
Trading volume
1.0×
vs its normal volume
Up days
4/7
Green days this week
52-week spot
3%
Position in 1-year range
Trades around ৳6.6 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
Watch-outs
ORIONINFU scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| ORIONINFU | 55 | ৳298 | +2.5% | 173.0 | +0.7% | +10.7% |
Who's behind this company — and how committed are they? As of Mar 2026, compared with Jun 2025.
Good sign — big institutions raised their stake from 13.1% to 16.3% since Jun 2025. People close to the company are buying.
Owners (sponsors) hold 41% — a strong sign of commitment.
Recent news and announcements about this company.